294 related articles for article (PubMed ID: 32382318)
1. Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status.
Greco A; Capodanno D
Interv Cardiol; 2020 Apr; 15():e02. PubMed ID: 32382318
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy after transcatheter aortic valve implantation.
Greco A; Spagnolo M; Capodanno D
Expert Rev Med Devices; 2022 Jun; 19(6):499-513. PubMed ID: 35881777
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update.
Greco A; Capranzano P; Barbanti M; Tamburino C; Capodanno D
Expert Rev Cardiovasc Ther; 2019 Jul; 17(7):479-496. PubMed ID: 31198065
[No Abstract] [Full Text] [Related]
4. Antithrombotic management after transcatheter aortic valve implantation.
McHugh F; Ahmed K; Neylon A; Sharif F; Mylotte D
J Thorac Dis; 2018 Nov; 10(Suppl 30):S3620-S3628. PubMed ID: 30505544
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic Management for Transcatheter Aortic Valve Implantation.
Ya'Qoub L; Arnautovic J; Sharkawi M; AlAasnag M; Jneid H; Elgendy IY
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137701
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolic and Bleeding Complications in Transcatheter Aortic Valve Implantation: Insights on Mechanisms, Prophylaxis and Therapy.
Ranasinghe MP; Peter K; McFadyen JD
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30823621
[TBL] [Abstract][Full Text] [Related]
7. What is the current optimal antithrombotic therapy after transcatheter aortic valve implantation? Current evidence from Japan and the world.
Kobari Y; Hayashida K;
J Cardiol; 2024 Mar; 83(3):141-148. PubMed ID: 37524301
[TBL] [Abstract][Full Text] [Related]
8. Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA
Heart Lung Circ; 2022 Aug; 31(8):1144-1152. PubMed ID: 35637093
[TBL] [Abstract][Full Text] [Related]
9. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation.
Geis NA; Kiriakou C; Chorianopoulos E; Uhlmann L; Katus HA; Bekeredjian R
Clin Res Cardiol; 2018 Sep; 107(9):799-806. PubMed ID: 29644411
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
Capodanno D; Collet JP; Dangas G; Montalescot G; Ten Berg JM; Windecker S; Angiolillo DJ
JACC Cardiovasc Interv; 2021 Aug; 14(15):1688-1703. PubMed ID: 34353601
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
Ferstl P; Achenbach S; Marwan M; Bittner DO
Int J Cardiol; 2023 Sep; 386():104-108. PubMed ID: 37244382
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
[TBL] [Abstract][Full Text] [Related]
13. Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation.
Lynch DR; Dantzler D; Robbins M; Zhao D
J Thromb Thrombolysis; 2013 May; 35(4):476-82. PubMed ID: 23420510
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
Ke Y; Wang J; Wang W; Guo S; Dai M; Wu L; Bao Y; Li B; Ju J; Xu H; Jin Y
Int J Cardiol; 2022 Sep; 362():139-146. PubMed ID: 35654173
[TBL] [Abstract][Full Text] [Related]
15. Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
van Ginkel DJ; Bor WL; Veenstra L; van 't Hof AWJ; Fabris E
Eur J Intern Med; 2022 Jul; 101():14-20. PubMed ID: 35623935
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM
Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.
Robert P; Akodad M; Lattuca B; Gandet T; Macia JC; Schmutz L; Delseny D; Piot C; Leclercq F; Cayla G
Catheter Cardiovasc Interv; 2022 Aug; 100(2):235-242. PubMed ID: 35661552
[TBL] [Abstract][Full Text] [Related]
18. Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
Hohmann C; Pfister R; Frerker C; Beckmann A; Walther T; Bleiziffer S; Ensminger S; Bekeredjian R; Seiffert M; Sinning JM; Möllmann H; Beyersdorf F; Baldus S; Böning A; Herrmann E; Balaban Ü; Kuhn E;
Heart; 2023 Oct; 109(22):1706-1713. PubMed ID: 37407220
[TBL] [Abstract][Full Text] [Related]
19. Thrombo-embolic prevention after transcatheter aortic valve implantation.
Vranckx P; Windecker S; Welsh RC; Valgimigli M; Mehran R; Dangas G
Eur Heart J; 2017 Dec; 38(45):3341-3350. PubMed ID: 29020333
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
